{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:34:34Z","timestamp":1790274874709,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.cbi.2005.10.031","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T07:20:54Z","timestamp":1130397654000},"page":"239-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman"],"prefix":"10.1016","volume":"157-158","author":[{"given":"Richard K.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R.","family":"Feaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra P.","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2005.10.031_bib1","series-title":"The Biology of Cholinesterases","author":"Silver","year":"1974"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2005.10.031_bib2","first-page":"113","article-title":"Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk","volume":"21","author":"Lockridge","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2005.10.031_bib3","unstructured":"P. Taylor, in: A.G., Gilman, T.W., Rall, A.S., Neis, P., Taylor (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, eighth ed., 1990, pp. 131\u2013149."},{"key":"10.1016\/j.cbi.2005.10.031_bib4","series-title":"Clinical and Experimental Toxicology of Organophosphates and Carbamates","first-page":"15","article-title":"Biochemical determination of cholinesterase activity in biological fluids and tissues","author":"Omer","year":"1992"},{"issue":"10","key":"10.1016\/j.cbi.2005.10.031_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00003088-200241100-00003","article-title":"Clinical Pharmacokinetics and pharmacodynamics of cholinesterase inhibitors","volume":"41","author":"Jann","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.cbi.2005.10.031_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00325481.1993.11945736","article-title":"Myasthenia gravis. Diagnostic methods and control measures for a chronic disease","volume":"94","author":"Juhn","year":"1993","journal-title":"Postgrad Med."},{"key":"10.1016\/j.cbi.2005.10.031_bib7","doi-asserted-by":"crossref","unstructured":"L. Ember, Probe of troop's exposure to chemical arms failed, Chem. Eng. News, 1996, pp. 40\u201341.","DOI":"10.1021\/cen-v074n039.p040"},{"issue":"3","key":"10.1016\/j.cbi.2005.10.031_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/milmed\/168.3.186","article-title":"Identifying new diseases and their causes: the dilemma of illnesses in Gulf War veterans","volume":"168","author":"Gardner","year":"2003","journal-title":"Mil. Med."},{"issue":"1","key":"10.1016\/j.cbi.2005.10.031_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/009841096161456","article-title":"Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures","volume":"48","author":"Abou-Donia","year":"1996","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.cbi.2005.10.031_bib10","unstructured":"S. Feaster, R. Gordon, B. Doctor, Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof. US patent # 6,746,850, Issued June 8, 2004."},{"key":"10.1016\/j.cbi.2005.10.031_bib11","unstructured":"S.R. Feaster, R.K. Gordon, C.C. Clark, D.M. Maxwell, D.E. Lenz, B.P. Doctor, Unprocessed Whole Blood Cholinesterase Levels: WRAIR Protocol Development and Validation. USAMRMC Bioscience Review, 2000, Hunt Valley, MD."},{"key":"10.1016\/j.cbi.2005.10.031_bib12","unstructured":"J.R. Haigh, G.E. Garcia, D.R. Moorad-Doctor, M.S. Farah, R. Brueckner, S.R. Feaster, B.P. Doctor, R.K. Gordon, D.E. Lenz, C.R. Clark, M.R. Riel, P.S. Aisen, W. Smart, J. Mo, B.J. Sullivan, Jr.-H. Tsai, The WRAIR Whole Blood Cholinesterase Assay\u2014Current Pyridostigmine Bromide and Huperzine A Studies and Future Cholinesterase Screening. USAMRMC Bioscience Review, 2004, Hunt Valley, MD."},{"issue":"21","key":"10.1016\/j.cbi.2005.10.031_bib13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2174\/0929867033456747","article-title":"Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional medicine origin for the treatment of Alzheimer's disease","volume":"10","author":"Jiang","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2005.10.031_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-4838(99)00085-0","article-title":"Multi-enzyme kinetic analysis of glycolipid biosynthesis","volume":"1432","author":"Bieberich","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2005.10.031_bib15","unstructured":"G.E. Garcia, D. Moorad-Doctor, Novel and sensitive pyridostigmine bromide HPLC assay. USAMRMC Bioscience Review, 2004, Hunt Valley, MD."},{"key":"10.1016\/j.cbi.2005.10.031_bib16","unstructured":"http:\/\/www.fda.gov\/cder\/drug\/infopage\/Pyridostigmine_Bromide\/default.htm."},{"issue":"Suppl. 1","key":"10.1016\/j.cbi.2005.10.031_bib17","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/jat.805","article-title":"The NMDA receptor ion channel: a site for binding of Huperzine A","author":"Gordon","year":"2001","journal-title":"J Appl. Toxicol."},{"key":"10.1016\/j.cbi.2005.10.031_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-813X(02)00015-3","article-title":"Review of the value of huperzine as pretreatment of organophosphate poisoning","volume":"23","author":"Lallement","year":"2002","journal-title":"Neurotoxicology"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279705002723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279705002723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:12:57Z","timestamp":1757855577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279705002723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":18,"alternative-id":["S0009279705002723"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2005.10.031","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2005.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}